Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Recently issued patent covers new nicotinic acetylcholine receptor antagonists

July 28, 2000

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

Beneficial effects of 4-AP in relapsing-remitting multiple sclerosis

July 27, 2000

5-HT2C antagonists potentiate the effects of dopaminergic drugs in PD

July 27, 2000

5-HT1A antagonist WAY-100635 reduces cognitive impairment in marmosets

July 27, 2000

Antibiotic demonstrates efficacy in mouse model of Huntington's disease

July 26, 2000

NK1 antagonist inhibits acute and delayed cisplatin-induced emesis in ferrets

July 26, 2000

Piperazine-based tachykinin receptor antagonists identified by Fujisawa

July 26, 2000

Novel paroxetine derivative and salts patented by SB

July 26, 2000

Favorable safety and efficacy profile seen for IQB-9302 in early clinical trial

July 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...